Claritas Pharmaceuticals Inc
Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.
Claritas Pharmaceuticals Inc (CLAZF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2021: -0.086x
Based on the latest financial reports, Claritas Pharmaceuticals Inc (CLAZF) has a cash flow conversion efficiency ratio of -0.086x as of September 2021.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-281.00K) by net assets ($3.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Claritas Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2005–2020)
This chart illustrates how Claritas Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Claritas Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Claritas Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Synergy Grid and Development Phils Inc
PSE:SGP
|
0.216x |
|
Everyman Media Group plc
LSE:EMAN
|
0.105x |
|
Wolf Energy Services Inc.
PINK:WOEN
|
0.214x |
|
SMT
VN:SMT
|
N/A |
|
DATANG INTL POW -H-
MU:BJI
|
N/A |
|
Ingdan Inc
STU:7C3
|
N/A |
|
PACIFIC CENTURY (PFQ.SG)
STU:PFQ
|
-0.006x |
|
Well Chip Group Berhad
KLSE:5325
|
N/A |
Annual Cash Flow Conversion Efficiency for Claritas Pharmaceuticals Inc (2005–2020)
The table below shows the annual cash flow conversion efficiency of Claritas Pharmaceuticals Inc from 2005 to 2020.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-12-31 | $1.51 Million | $-309.00K | -0.205x | -110.87% |
| 2019-12-31 | $-3.44 Million | $-6.48 Million | 1.886x | +479.89% |
| 2018-12-31 | $9.76 Million | $-4.85 Million | -0.497x | -203.87% |
| 2017-12-31 | $-11.63 Million | $-5.56 Million | 0.478x | +185.23% |
| 2016-12-31 | $2.92 Million | $-1.64 Million | -0.561x | +78.15% |
| 2015-12-31 | $441.00K | $-1.13 Million | -2.567x | -314.43% |
| 2014-12-31 | $-1.24 Million | $-1.48 Million | 1.197x | -74.48% |
| 2013-12-31 | $-1.22 Million | $-5.71 Million | 4.692x | +8522.76% |
| 2012-12-31 | $21.18 Million | $-1.18 Million | -0.056x | +79.38% |
| 2011-12-31 | $45.34 Million | $-12.25 Million | -0.270x | -1130.21% |
| 2010-12-31 | $34.59 Million | $-759.32K | -0.022x | +82.13% |
| 2009-12-31 | $24.61 Million | $-3.02 Million | -0.123x | +52.18% |
| 2008-12-31 | $9.37 Million | $-2.41 Million | -0.257x | -1198.71% |
| 2007-12-31 | $29.15 Million | $-576.66K | -0.020x | +87.05% |
| 2006-12-31 | $705.46K | $-107.74K | -0.153x | +14.42% |
| 2005-12-31 | $989.76K | $-176.64K | -0.178x | -- |